| Dokumenttyp | Erscheinungsjahr | Titel | Autoren | Herausgeber |
|---|
| Other | 2024 | Mast Cell Sarcoma Mimicking Lymphoma or Metastatic Disease on 18 F-FDG PET/CT | Rosar, Florian; Ezziddin, Samer; Bittenbring, Jörg Thomas; Christofyllakis, Konstantinos; Burgard, Caroline | |
| article | 2024 | Ectopic Cushing Syndrome Localized by 68 Ga-DOTA-LM3 PET/CT | Bastian, Moritz B.; Rosar, Florian; Burgard, Caroline; Blickle, Arne; Ezziddin, Samer | |
| article | 2024 | Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study) | Rosar, Florian; Schuler, Joelle; Burgard, Caroline; Blickle, Arne; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Khreish, Fadi; Schaefer, Andrea; Ezziddin, Samer | |
| article | 2024 | Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform | Martin, Sebastian; Schreck, Moritz-Valentin; Stemler, Tobias; Maus, Stephan; Rosar, Florian; Burgard, Caroline; Schaefer-Schuler, Andrea; Ezziddin, Samer; Bartholomä, Mark D. | |
| article | 2024 | First Successful In-Human Application of 225Ac-DOTA-LM3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3) | Speicher, Tilman; Burgard, Caroline; Bastian, Moritz; Rosar, Florian; Bartholomä, Mark; Maus, Stephan; Ezziddin, Samer | |
| article | 2024 | Diffuse Peritoneal Carcinomatosis of Prostate Cancer Unveiled by [89Zr]Zr-PSMA-617 PET/CT | Bastian, Moritz B.; Burgard, Caroline; Blickle, Arne; Ezziddin, Samer; Rosar, Florian | |
| article | 2024 | Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in mCRPC Patients With Preexisting Impaired Renal Function | Bastian, Moritz B.; Sieben, Maike; Burgard, Caroline; Blickle, Arne; Speicher, Tilman; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Schaefer-Schuler, Andrea; Ezziddin, Samer; Rosar, Florian | |
| article | 2024 | [89Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Prior Indetermined Findings on [18F]PSMA-1007 Imaging | Bastian, Moritz B.; Burgard, Caroline; Blickle, Arne; Speicher, Tilman; Ezziddin, Samer; Rosar, Florian | |
| article | 2024 | Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy | Burgard, Caroline; Khreish, Fadi; Dahlmanns, Lukas; Blickle, Arne; Bastian, Moritz B.; Speicher, Tilman; Maus, Stephan; Schaefer-Schuler, Andrea; Bartholomä, Mark; Petto, Sven; Ezziddin, Samer; Rosar | |
| article | 2024 | Cutting the Gordian Knot: Rare Presentation of Nodular Fasciitis as Supraclavicular Swelling with Muscular Involvement in 68Ga-FAPI-PET/CT | Brust, Lukas A.; Höh, Madeleine; Linxweiler, Maximilian; Bozzato, Alessandro; Burgard, Caroline; Rosar, Florian; Altmeyer, Katrin; Lessenich, Carl P.; Kohlwes, Elke; Pillong, Lukas | |
| article | 2024 | Outstanding increase in tumor-to-background ratio over time allows tumor localization by [89Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer | Burgard, Caroline; Rosar, Florian; Larsen, Elena; Khreish, Fadi; Linxweiler, Johannes; Marlowe, Robert J.; Schaefer-Schuler, Andrea; Maus, Stephan; Petto, Sven; Bartholomä, Mark; Ezziddin, Samer | |
| article | 2023 | Radiometal Complexes as Pharmacokinetic Modifiers: A Potent 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me | Schreck, Moritz-Valentin; Burgard, Caroline; Schmidtke, Alexander; Hierlmeier, Ina; Stemler, Tobias; Maus, Stephan; Rosar, Florian; Jung, Martin; Speicher, Andreas; Ezziddin, Samer; Holland, Jason P.; Bartholomä, Mark D. | |
https://orcid.org/0009-0008-5515-4636